InsiderTrades.com logo
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...
Clive Meanwell net worth and biography
  • LinkedIn
  • Phone

Clive Meanwell Biography and Net Worth

CEO of Population Health Investment
Dr. Clive A. Meanwell is a Chief Executive Officer & Director at Population Health Investment Co., Inc., a Chief Executive Officer at Rempex Pharmaceuticals, Inc., a Director & Chief Innovation Officer at The Medicines Co. and an Executive Chairman at Population Health Partners LLC. He is on the Board of Directors at Population Health Investment Co., Inc., BB Biotech AG, Pharmaceutical Research & Manufacturers of America and The Medicines Co. Dr. Meanwell was previously employed as a Chief Innovation Officer & Director by The Medicines Co., a Managing Director & Partner by MPM Capital Inc, a Senior Vice President by Hoffmann-La Roche, Inc., and a President by Targanta Therapeutics Corp. He also served on the board at Endo Pharmaceuticals Holdings, Inc. He received his doctorate degree from the University of Birmingham.

What is Clive Meanwell's net worth?

The estimated net worth of Clive Meanwell is at least $164,492.00 as of August 24th, 2021. Dr. Meanwell owns 16,400 shares of Population Health Investment stock worth more than $164,492 as of April 25th. This net worth approximation does not reflect any other investments that Dr. Meanwell may own. Learn More about Clive Meanwell's net worth.

How old is Clive Meanwell?

Dr. Meanwell is currently 64 years old. There are 5 older executives and no younger executives at Population Health Investment. Learn More on Clive Meanwell's age.

Has Clive Meanwell been buying or selling shares of Population Health Investment?

Clive Meanwell has not been actively trading shares of Population Health Investment during the last quarter. Most recently, on Tuesday, August 24th, Clive Meanwell bought 16,400 shares of Population Health Investment stock. The stock was acquired at an average cost of $9.80 per share, with a total value of $160,720.00. Following the completion of the transaction, the chief executive officer now directly owns 16,400 shares of the company's stock, valued at $160,720. Learn More on Clive Meanwell's trading history.

Clive Meanwell Insider Trading History at Population Health Investment

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/24/2021Buy16,400$9.80$160,720.0016,400View SEC Filing Icon  
See Full Table

Clive Meanwell Buying and Selling Activity at Population Health Investment

This chart shows Clive Meanwell's buying and selling at Population Health Investment by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Population Health Investment Company Overview

Population Health Investment logo
Population Health Investment Co., Inc. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Read More

Today's Range

Now: $10.03
Low: $10.03
High: $10.03

50 Day Range

MA: $10.03
Low: $10.03
High: $10.03

2 Week Range

Now: $10.03
Low: $9.80
High: $10.31

Volume

655 shs

Average Volume

3,382 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...